Clinical Trials Directory

Trials / Conditions / Transformed Follicular Lymphoma (TFL)

Transformed Follicular Lymphoma (TFL)

8 registered clinical trials studyying Transformed Follicular Lymphoma (TFL) — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies
NCT07476378
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
Enrolling By InvitationCD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
University of Maryland, BaltimorePhase 1
RecruitingP-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
NCT06014762
Poseida Therapeutics, Inc.Phase 1
RecruitingStudy of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients
NCT07473167
TICAROS Co., Ltd.Phase 1 / Phase 2
RecruitingStudy of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
NCT04836507
Curocell Inc.Phase 1 / Phase 2
Active Not RecruitingOptimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
NCT04745559
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
Active Not RecruitingENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
NCT04049513
Malaghan Institute of Medical ResearchPhase 1
CompletedStudy Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgk
NCT02348216
Kite, A Gilead CompanyPhase 1 / Phase 2